First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination Moran Shapira, M.D., Hila Raanani, M.D., Iris Barshack, M.D., Ninette Amariglio, M.D., Ph.D., Sanaz Derech-Haim, M.Sc., Meital Nagar Marciano, Ph.D., Eyal Schiff, M.D., Raoul Orvieto, M.D., Dror Meirow, M.D. Fertility and Sterility Volume 109, Issue 1, Pages 48-53 (January 2018) DOI: 10.1016/j.fertnstert.2017.09.001 Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions
Figure 1 (A) Hematoxylin and eosin ovarian cortex histology after exposure to consolidation chemotherapy and before ablative chemotherapy treatment and bone marrow transplantation. The cortex shows abundant ovarian follicles with no leukemic cells. At this stage histology is the only method indicating that the patient is not sterilized. (B) Cancer detection tests tailored to the patient. Fertility and Sterility 2018 109, 48-53DOI: (10.1016/j.fertnstert.2017.09.001) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions